Running projects

A number of projects are currently running at InGell Labs both strategically and customer oriented:

  1. Screening the potential of "InGell Gamma" towards controlled release of various relevant bioactive molecules (small molecules, peptides and proteins);
  2. Stretching the potential of "InGell Gamma" towards controlled release of hydrophilic proteins for a period up to 3 months or more;
  3. Intra-articular injection of hydrogels loaded with anti-inflammatory compounds for treatment of osteo-arthritis;
  4. Intervertebral disc regeneration by intra-disc injection of hydrogels with anti-inflammatory compounds or proteins;
  5. Working towards long-term systemic delivery formulations of small molecules and peptides;
  6. General dosing and shelving strategies;
  7. Scaling up and cGMP routing for the polymers; 
  8. Shelf-life and biostability/biodegradation studies.